Rachel Greenwald

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

A. Osunkoya, V. Master, O. Kucuk, 2022, Journal for ImmunoTherapy of Cancer.

Clinical and immunological response to checkpoint therapy in renal cell carcinoma is associated with TCF1+ CD8 T-cells in the tumor

A. Osunkoya, V. Master, O. Kucuk, 2021 .

929 Dissecting intratumoral immune organization: defining the comparative cellular composition of tertiary lymphoid structures T-cell supportive antigen presenting niches in renal tumors

A. Osunkoya, V. Master, M. Bilen, 2021, Journal for ImmunoTherapy of Cancer.